
Global Molecular Imaging Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
346
-
Jan 2022
-
157
-
PDF
-
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
MarketResearch.Biz delivers in-depth insights in its upcoming report titled “Global Molecular Imaging Devices Market: Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global molecular imaging devices market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global molecular imaging devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global molecular imaging devices market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global molecular imaging devices market report has been segmented on the basis of techniques, applications and region.
Molecular imaging is a biomedical discipline that provides detailed visualizations and measurement of biologic processes taking place inside the body at molecular, cellular, and genetic level. Molecular imaging technique is used to detect and understand disease complexities in a more efficient manner, by finding abnormalities and malfunctioning areas in an individual.
Various techniques that have been used in molecular imaging includes Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), X-ray Computed Tomography (CT), ultrasound, optical imaging, single photon emission computed tomography (SPECT) and various others. Amongst all other techniques, photon emission tomography (PET) and SPCET are most widely used due to their ability to allow interrogation at detailed tissue depths. PET and SPCET scanners generate images of the lung, liver, and heart, and also provide information about an organ’s metabolism and other functions.
High incidence of cancer and cardiovascular diseases and increasing demand for accurate and efficient imaging systems for detection of abnormalities in the human body are key factors driving growth of the global molecular imaging devices market. Technological advancements in the fields of nanotechnology and robotics, increasing aging population, and rising adoption of hybrid imaging technologies are major factors driving growth of global molecular imaging devices market. In addition, this trend is expected to continue over the forecast period.
However, high cost of molecular imaging devices is a key restraint for growth of the global molecular imaging devices market currently. In addition, high product development costs, brand loyalty, and competitive pricing are major factors expected to hamper growth of global molecular imaging devices market to a certain extent over the forecast period.
Entry into the global molecular imaging devices market is restricted to new entrants, owing to high demand for complex technologies and strong financials to procure required equipment and systems. As a result, major trends witnessed in the global molecular imaging devices market are mergers and acquisitions, and licensing deals between major players.
North America dominated the global molecular imaging devices market in terms of revenue share, owing to high level of adoption of imaging devices in the healthcare industry. Europe accounted for second largest market share contribution to the global molecular imaging devices market, followed by Asia Pacific. Markets in emerging economies in Asia Pacific such as India and China are anticipated to expand at the highest CAGR of X.X% over the forecast period, due to rise in competitive business and easy availability of appropriate infrastructure in this region.
Global Molecular Imaging Devices Market Segmentation:
Global molecular imaging devices market segmentation by technique:
- PET
- SPECT
- MRI
- MRS
- CT
- Ultrasound
Global molecular imaging devices market segmentation by application:
- Cardio Vascular
- Neurology
- Oncology
Global molecular imaging devices market segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- Philips
- Siemens
- GE Healthcare Affibody
- Cyclopharma
- Perkin-Elmer
- Hamamatsu Photonics
- Scintomics
- Naviscanand Kereos
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!